Good Medicine Podcast

On this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a raw and insightful conversation about obesity, weight loss, and the explosive rise of GLP-1 drugs. Together, they explore:The personal and societal toll of obesityHow GLP-1 medications are reshaping the weight loss landscapeThe science behind these treatments — and the hypeWhy lifestyle still matters, even...

This week on Good Medicine , we sit down with Henry O’Connell, CEO of Canary Speech, a company using vocal biomarkers to revolutionize mental and neurological health diagnostics. With a career spanning leadership roles at NIH, HP, and MOXTEK, Henry brings decades of insight into how technology can transform healthcare. In this episode, he explains how Canary’s voice analysis tools are giving docto...

In this episode of Good Medicine, David Bearss sits down with John Lippert, founder and Chief Technology Officer at Scientia. With a career spanning decades in the medical device industry, John shares insights from his work in neurovascular innovation, startup leadership, and the evolution of less-invasive medicine. As the founder of both Scientia Vascular and Precision Vascular Systems—and with a...

In this episode of Good Medicine, Dr. Bearss sits down with Mark Paul, a veteran of the medical device industry, to explore the intersection of innovation, engineering, and patient care. Mark shares lessons from a decades-long career — from early product development to scaling companies that have improved countless lives. He reflects on the mindset needed to lead teams, solve real-world problems,...

This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and public trust—while also examining the growing debates around how they operate. From differing perspectives across industry, academia, and government, Dave unpacks the complex views on what should evolve...

In this episode of Good Medicine , Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to explore the cutting edge of neurodegenerative disease research. They dive deep into the science behind treating Alzheimer’s, Parkinson’s, ALS, and other brain disorders — including how Denali is tackling one of the biggest challenges in medicine: getting therapies across the blood-brain barr...

In this solo episode, Dr. Bearss breaks down the controversial “Most Favored Nation” (MFN) drug pricing rule introduced during the Trump administration. What is the policy aiming to solve? How would it change the cost of prescription drugs in the U.S.? And why did it stir such intense debate across the healthcare and pharmaceutical industries? With clear, research-backed insight, David explores th...

In this episode of the podcast, Dr. David Bearss sits down with Dr. Chris Gibson, Co-Founder and CEO of Recursion. Dr. Gibson shares his journey from graduate research at the University of Utah to building Recursion into one of the most advanced AI-driven drug discovery companies in the world. They discuss the intersection of biology and machine learning, the future of drug development, and how Re...

In this special episode of the Good Medicine Podcast, Kelvyn Cullimore sits down with Dr. David Bearss for a wide-ranging conversation that gives listeners a chance to get to know the voice behind the mic. From his early life and scientific journey to what motivates his work today, Dr. Bearss opens up about his path, passions, and perspective on the future of healthcare and innovation. 🎧 Tune in...

On this episode of the Good MedicinePodcast, we discuss why drugs are so expensive. We break down the complex world of drug pricing—from research and development costs to patent protections, insurance dynamics, and the roles of pharmaceutical companies and middlemen. Whether you’re a curious patient, healthcare professional, or just wondering why your prescriptions keep getting more expensive, thi...

Dr. Joshua Schiffman is a pediatric hematologist-oncologist and Professor of Pediatrics and Investigator at Huntsman Cancer Institute at the University of Utah. Dr. Schiffman is passionate about introducing new medicines for patients with cancer and inflammatory diseases. Sponsors BioHive: https://www.biohive.com/ Galvan: https: https://www.galvan.health/ Follow Good Medicine Podcast Insta: https:...

Dr. David Bearss welcomes you to the podcast with a short introduction.